Related Experiment Video

Updated: Aug 23, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

In silico simulation of inhibitor drug effects on nuclear factor-kappaB pathway dynamics

Myong-Hee Sung1, Richard Simon

  • 1Biometric Research Branch, National Cancer Institute, National Institutes of Health, 6130 Executive Blvd. EPN 8146, MSC 7434, Bethesda, MD 20892, USA. sungm@mail.nih.gov

Molecular Pharmacology
|June 24, 2004
PubMed

Insights

Inhibiting the NF-kappaB pathway shows distinct effects based on the drug target. Upstream inhibition may lead to greater oscillations than direct NF-kappaB inhibition, aiding cancer therapy development.

Area of Science:

  • Molecular Biology
  • Systems Biology
  • Pharmacology

Background:

  • Nuclear factor kappa B (NF-kappaB) is a transcription factor family regulating genes involved in cell survival, apoptosis, and migration.
  • Persistent NF-kappaB activity is linked to tumor formation, growth, metastasis, and drug resistance in various cancers.
  • Current therapies target NF-kappaB by blocking specific pathway components with small molecules.

Purpose of the Study:

  • To investigate the in silico effects of inhibitors targeting different components of the NF-kappaB pathway.
  • To analyze the distinct target-specific dynamic profiles of pathway inhibition.
  • To compare the dynamic effects of various inhibitors, including bortezomib, considering pharmacokinetics.

Main Methods:

  • Utilized a kinetic model of the NF-kappaB pathway to simulate perturbed system dynamics.
  • Examined the time course of inhibition for different targeted network components.
  • Assessed the oscillatory potential of inhibition at varying drug concentrations.

Main Results:

  • Inhibition of upstream NF-kappaB pathway events demonstrated greater oscillatory potential compared to direct NF-kappaB inhibition at low drug concentrations.
  • Distinct target-specific profiles were observed in the time course of inhibition.
  • Dynamic effects of bortezomib (PS-341) were analyzed and compared with other inhibitors.

Conclusions:

  • Kinetic analysis of the NF-kappaB pathway under drug perturbation provides insights into target-specific inhibition dynamics.
  • Understanding these dynamics can facilitate optimal drug target selection for molecularly targeted cancer therapies.
  • This approach aids in developing effective treatment protocols for cancers associated with aberrant NF-kappaB signaling.

More Related Videos

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...